Vasoactive intestinal peptide increases VEGF expression to promote proliferation of brain vascular endothelial cells via the cAMP/PKA pathway after ischemic insult in vitro

Peptides

Volumn 42, Issue , 2013, Pages 105-111

  Yang, Jie ^a   Shi, Qing Dong ^a   Song, Tian Bao ^a   Feng, Gai Feng ^a   Zang, Wei Jing ^a   Zong, Chang Hong ^a   Chang, Ling ^b  

^a XI'AN JIAOTONG UNIVERSITY   (China)

^b XI AN ELECTRONIC ENGINEERING RESEARCH INSTITUTE   (China)

Author keywords

Brain microvascular endothelial cells; CAMP; Oxygen and glucose deprivation; Vascular endothelial growth factor; Vasoactive intestinal peptide

Indexed keywords

CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; DUAL SPECIFICITY PHOSPHATASE 2; VASCULOTROPIN; VASOACTIVE INTESTINAL POLYPEPTIDE; VASOACTIVE INTESTINAL POLYPEPTIDE RECEPTOR 1; VASOACTIVE INTESTINAL POLYPEPTIDE RECEPTOR 2;

ANGIOGENESIS; ARTICLE; BRAIN ISCHEMIA; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOCYTOCHEMISTRY; IN VITRO STUDY; MICROVASCULAR ENDOTHELIAL CELL; NEWBORN; NONHUMAN; PHARMACOLOGICAL BLOCKING; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; WESTERN BLOTTING;

ANIMALS; BRAIN; BRAIN ISCHEMIA; CELL PROLIFERATION; CELLS, CULTURED; CYCLIC AMP; CYCLIC AMP-DEPENDENT PROTEIN KINASES; ENDOTHELIAL CELLS; GLUCOSE; OXYGEN; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, VASOACTIVE INTESTINAL PEPTIDE; RECEPTORS, VASOACTIVE INTESTINAL PEPTIDE, TYPE II; RECEPTORS, VASOACTIVE INTESTINAL POLYPEPTIDE, TYPE I; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASOACTIVE INTESTINAL PEPTIDE;

RATTUS;

EID: 84874602909     PISSN: 01969781     EISSN: 18735169     Source Type: Journal    
DOI: 10.1016/j.peptides.2013.01.007     Document Type: Article

References (34)

1. D.E. Brenneman Neuroprotection: a comparative view of vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide Peptides 28 2007 1720 1726
2. M. Casibang, S. Purdom, S. Jacolew, L. Neckers, F. Zia, and P. Ben-Av Prostaglandin E2 and vasoactive intestinal peptide increase vascular endothelial growth factor mRNAs in lung cancer cells Lung Cancer 31 2001 203 213
3. A. Castorina, S. Giunta, V. Mazzone, V. Cardile, and V. D'Agata Effects of PACAP and VIP on hyperglycemia-induced proliferation in murine microvascular endothelial cells Peptides 31 2010 2276 2283
4. B. Collado, M.J. Carmena, C. Clemente, J.C. Prieto, and A.M. Bajo Vasoactive intestinal peptide enhances growth and angiogenesis of human experimental prostate cancer in a xenograft model Peptides 28 2007 1896 1901
5. B. Collado, I. Gutiérrez-Cañas, N. Rodríguez-Henche, J.C. Prieto, and M.J. Carmena Vasoactive intestinal peptide increases vascular endothelial growth factor expression and neuroendocrine differentiation in human prostate cancer LNCaP cells Regul Pept 119 2004 69 75
6. B. Collado, M.G. Sánchez, I. Díaz-Laviada, J.C. Prieto, and M.J. Carmena Vasoactive intestinal peptide (VIP) induces c-fos expression in LNCaP prostate cancer cells through a mechanism that involves Ca2+ signalling. Implications in angiogenesis and neuroendocrine differentiation Biochim Biophys Acta 1744 2005 224 233
7. G.J. del Zoppo, and T. Mabuchi Cerebral microvessel responses to focal ischemia J Cereb Blood Flow Metab 23 2003 879 894
8. J. Fahrenkrug, and S.I.V.I.P. Said PACAP, glucagons, and related peptides Ann N Y Acad Sci 921 2000 1 110
9. N. Ferrara, H.P. Gerber, and J. Le Couter The biology of VEGF and its receptors Nat Med 9 2003 669 676
10. V.A. Fishbein, D.H. Coy, S.J. Hocart, N.Y. Jiang, J.E. Mrozinski Jr., and S.A. Mantey A chimeric VIP- PACAP analogue but not VIP pseudopeptides function as VIP receptor antagonists Peptides 15 1994 95 100
11. J. Folkman Angiogenesis in cancer, vascular, rheumatoid and other disease Nat Med 1 1995 27 31
12. O. Gómez, and J.A. Balsa Autocrine/paracrine action of pituitary vasoactive intestinal peptide on lactotroph hyperplasia induced by estrogen Endocrinology 144 2003 4403 4409
13. A.J. Harmar, A. Arimura, I. Gozes, L. Journot, M. Laburthe, and J.R. Pisegna International Union of Pharmacology. XVIII. Nomenclature of receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide Pharmacol Rev 50 1998 265 270
14. D. Hu, C.R. Hiley, and T.P. Fan Comparative studies of the angiogenic activity of vasoactive intestinal peptide, endothelins-1 and -3 and angiotensin II in a rat sponge model Br J Pharmacol 117 1996 545 551
15. R. Issa, J. Krupinski, T. Bujny, S. Kumar, J. Kaluza, and P. Kumar Vascular endothelial growth factor and its receptor, KDR, in human brain tissue after ischemic stroke Lab Invest 79 1999 417 425
16. R.G. Jiang, X.Q. Zhang, and C. Eyzaguirre Hypoxia induced by Na2S2O4 increases [Na+]i in mouse glomus cells, an effect depressed by cobalt. Experiments with Na+-selective microelectrodes and voltage-clamping Brain Res 797 1998 197 208
17. K.M. Joo, Y.H. Chung, M.K. Kim, R.H. Nam, B.L. Lee, and K.H. Lee Distribution of vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide receptors (VPAC1, VPAC2, and PAC1 receptor) in the rat brain J Comp Neurol 476 2004 388 413
18. K.J. Kim, B. Li, K. Houck, J. Winer, and N. Ferrara The vascular endothelial growth factor proteins: identification of biologically relevant regions by neutralizing monoclonal antibodies Growth Factors 7 1992 53 64
19. I. Klaska, K. Bednarek, and J.Z. Nowak Effects of PEDF and VEGF on PACAP-/VIP induced cAMP formation in rat brain derived astrocyte cultures Pharmacol Rep 60 2008 1019 1024
20. J.M. Krum, and A. Khaibullina Inhibition of endogenous VEGF impedes revascularization and astroglial proliferation: roles for VEGF in brain repair Exp Neurol 181 2003 241 257
21. J. Krupinski, J. Kaluza, P. Kumar, S. Kumar, and J.M. Wang Role of angiogenesis in patients with cerebral ischemic stroke Stroke 25 1994 1794 1798
22. D. Lange, K. Funa, A. Ishisaki, R. Bauer, and U. Wollina Autocrine endothelial regulation in brain stem vessels of newborn piglets Histol Histopathol 14 1999 821 825
23. Y.H. Lin, A.H. Liu, Y. Pan, C. Westenbroek, G.J. Ter Horst, and H.M. Yu Reduction in the in vitro expression of brain-pancreas relative protein by oxygen and glucose-deprivation Mol Cell Biochem 295 2007 199 204
24. H.J. Marti, M. Bernaudin, A. Bellail, H. Schoch, M. Euler, and E. Petit Hypoxia-induced vascular endothelial growth factor expression precedes neovascularization after cerebral ischemia Am J Pathol 156 2000 965 976
25. T.W. Moody, J.M. Hill, and R.T. Jensen VIP as a trophic factor in the CNS and cancer cells Peptides 24 2003 163 177
26. D. Ribatti, M.T. Conconi, and G.G. Nussdorfer Nonclassic endogenous novel [corrected] regulators of angiogenesis Pharmacol Rev 59 2007 185 205
27. W. Risau Mechanisms of angiogenesis Nature 386 1997 671 674
28. D. Shweiki, A. Itin, D. Soffer, and E. Keshet Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis Nature 359 1992 843 845
29. M. Slevin, J. Krupinski, A. Slowik, P. Kumar, A. Szczudlik, and J. Gaffney Serial measurement of vascular endothelial growth factor and transforming growth factor-beta1 in serum of patients with acute ischemic stroke Stroke 31 2000 1863 1870
30. A. Valdehita, M.J. Carmena, B. Collado, J.C. Prieto, and A.M. Bajo Vasoactive intestinal peptide (VIP) increases vascular endothelial growth factor (VEGF) expression and secretion in human breast cancer cells Regul Pept 144 2007 101 108
31. J.K. Voice, G. Dorsam, R.C. Chan, C. Grinninger, Y. Kong, and E.J. Goetzl Immunoeffector and immunoregulatory activities of vasoactive intestinal peptide Regul Pept 109 2002 199 208
32. J. Yang, T.B. Song, Z.H. Zhao, S.D. Qiu, X.D. Hu, and L. Chang Vasoactive intestinal peptide protects against ischemic brain damage induced by focal cerebral ischemia in rats Brain Res 1398 2011 94 101
33. J. Yang, C.H. Zong, Z.H. Zhao, X.D. Hu, Q.D. Shi, and X.L. Xiao Vasoactive intestinal peptide in rats with focal cerebral ischemia enhances angiogenesis Neuroscience 161 2009 413 421
34. G. Zadeh, and A. Guha Angiogenesis in nervous system disorders Neurosurgery 539 2003 1362 1374